CYTOSKELETON AND PLATELET CLEARANCE
CYTOSKELETON AND PLATELET CLEARANCE
批准号:
9752679
负责人:
Perumal Thiagarajan
金额:
$39.63万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2022-05-31
关键词:
ActinsAgeAgonistApoptosisApoptoticBCL2 geneBindingBlood CirculationBlood Coagulation DisordersBlood PlateletsCASP3 geneCaspaseCell membraneCell surfaceCellsCollagenCollectionComplexCytoplasmCytoskeletal ProteinsCytoskeletonFailureFamilyGenerationsGenesGlycoprotein IbGrantHarvestHemostatic AgentsHepaticImpairmentIn VitroIntegral Membrane ProteinLeadLifeLongevityMammalian CellMediatingMembraneMitochondriaMolecularMovementMusMutagenesisMutationNuclearOuter Mitochondrial MembranePathway interactionsPhenotypePhosphatidylserinesPhospholipidsPhysiologyPlatelet ActivationPlatelet GlycoproteinsPolysaccharidesPreparationProtein FamilyProteinsRecoveryRegulationReportingRestRoleScott syndromeStructureSurfaceThrombinThrombocytopeniaTransfusionagedbcl-xlong proteincofilincytochrome cfunctional groupgenome-wideimprovedin vivomacrophagemolecular clocknovelphosphatidylserine receptorplatelet storageplatelet storage lesionprematurepreventreceptorresponsesenescencewasting
中文摘要
用于输血的血小板的“保质期”相对较短,为5天。随着储存量的增加,血小板
发生结构和功能变化,称为“血小板储存病变”。这些变化不仅导致
对激动剂的止血反应降低,但也加速了体内循环的清除。
已经提出了几种机制,包括血小板糖蛋白Ib复合物在血小板膜上的聚集。
血小板表面,聚糖改变导致肝Ashwell-Morell受体识别和脱落
血小板糖蛋白Ibα。磷脂酰丝氨酸(PS)暴露于储存的血小板表面是一个众所周知的标记
从流通中清除。在静息血小板中,PS位于膜双层的内叶
并且在储存期间和血小板聚集期间存在从内小叶到外小叶的跨双层运动
activation. PS暴露的衰老(或凋亡)诱导和激活依赖途径
已经描述了衰老血小板中PS的暴露通过线粒体Bcl-2家族发生,
蛋白质和(与激活诱导的PS暴露相反),它不需要升高胞质Ca+,
涉及细胞色素C释放和随后的半胱天冬酶3的活化。PS暴露同时发生
随着微粒的产生,储存的血小板制剂含有富含PS的微粒。的
维持静息血小板中磷脂不对称性的分子机制,如大多数哺乳动物
细胞是未知的。我们提出了一种新的机制,在存储过程中磷脂不对称的损失。
我们认为皮质肌动蛋白网络将PS限制在内叶,并假设在储存过程中,
细胞骨架的重组释放了对质膜双层的正常约束,导致细胞骨架的丧失。
阴离子磷脂的不对称性和跨双层运动。细胞骨架蛋白,紧密结合在
阴离子磷脂,如肌动蛋白,也可能与一个假定的
扰码相关机制。赠款的总体目标是阐明
维持新鲜血小板中的磷脂不对称性及其在储存期间的损失。本提案的具体目标
该提案的具体目标是:(1)确定皮质肌动蛋白网络的作用,
维持磷脂不对称性,(2)确定cofilin-1诱导的调节机制
PS暴露在储存的血小板中和(3)确定cofilin-1抑制对血小板存活的影响。
英文摘要
Platelets, harvested for transfusion, have a relatively short “shelf life” of 5 days. With increasing storage, platelets
develop structural and functional changes called “platelet storage lesions”. These changes result not only in
reduced hemostatic response to agonists but also in an accelerated clearance from the circulation in vivo.
Several mechanisms have been proposed including clustering of the platelet glycoprotein Ib complex on the
surface of platelets, alterations in glycans leading to recognition by hepatic Ashwell-Morell receptor and shedding
of platelet glycoprotein Ibα. Exposure of phosphatidylserine (PS) on stored platelet surface is a well known tag
for clearance from the circulation. In resting platelets, PS is located in the inner leaflet of the membrane bilayer
and there is transbilayer movement from the inner to the outer leaflet during storage and during platelet
activation. Both a senescence (or apoptosis)- induced and an activation-dependent pathways of PS exposure
have been described. Exposure of PS in senescent platelets occurs through the mitochondrial Bcl-2 family of
proteins and (in contrast to activation-induced PS exposure) it does not require elevation of cytosolic Ca+ and it
involves cytochrome c release and subsequent activation of caspase 3. PS exposure occurs simultaneously
with the generation of microparticles and stored platelet preparation contain PS-rich microparticles. The
molecular mechanisms that maintain the phospholipid asymmetry in resting platelets, as in most mammalian
cells, are not known. We propose a novel mechanism for the loss of phospholipid asymmetry during storage.
We posit that the cortical actin network confines PS to the inner leaflet and hypothesize that during storage the
reorganization of cytoskeleton releases normal constraints on plasma membrane bilayer leading to the loss of
asymmetry and transbilayer movement of anionic phospholipids. The cytoskeletal proteins, tightly bound to
anionic phospholipids such as actin, are also exteriorized to the cytoplasmic surface possibly with a putative
scramblase-dependent mechanism. The overall objective of the grant is to delineate the mechanisms that
maintain phospholipid asymmetry in fresh platelets and its loss during storage. Specific aims of this proposal
are: The specific aims of the proposal are (1) to determine the role of the cortical actin network in
maintaining the phospholipid asymmetry, (2) to define the mechanism of regulation of cofilin-1-induced
PS exposure in stored platelets and (3) to determine the effect of cofilin-1 inhibition on platelet survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Platelet Microvesicles
-
批准号:8195600
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Perumal Thiagarajan
-
依托单位:
Platelet Microvesicles
-
批准号:8542461
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Perumal Thiagarajan
-
依托单位:
Platelet Microvesicles
-
批准号:7907799
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Perumal Thiagarajan
-
依托单位:
Platelet Microvesicles
-
批准号:7791560
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Perumal Thiagarajan
-
依托单位:
Platelet Microvesicles
-
批准号:8391536
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Perumal Thiagarajan
-
依托单位:
Basic and Clinical Research Training in Thrombosis
-
批准号:7019108
-
项目类别:
-
资助金额:$21.22万
-
财政年份:2004
-
负责人:Perumal Thiagarajan
-
依托单位:
Basic and Clinical Research Training in Thrombosis
-
批准号:7218610
-
项目类别:
-
资助金额:$21.22万
-
财政年份:2004
-
负责人:Perumal Thiagarajan
-
依托单位:
Basic and Clinical Research Training in Thrombosis
-
批准号:7431613
-
项目类别:
-
资助金额:$17.31万
-
财政年份:2004
-
负责人:Perumal Thiagarajan
-
依托单位:
Shear induced platelet procoagulant activity
-
批准号:6584925
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2002
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6650264
-
项目类别:
-
资助金额:$22.69万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6587283
-
项目类别:
-
资助金额:$19.6万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6082268
-
项目类别:
-
资助金额:$22.55万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6185178
-
项目类别:
-
资助金额:$22.55万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6527590
-
项目类别:
-
资助金额:$22.69万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
ANTIBODIES WITH PROTHROMBINASE ACTIVITY IN LUPUS
-
批准号:6390762
-
项目类别:
-
资助金额:$2.94万
-
财政年份:1999
-
负责人:Perumal Thiagarajan
-
依托单位:
PLATELET-FIBRINOGEN INTERACTIONS
-
批准号:3358130
-
项目类别:
-
资助金额:$15.52万
-
财政年份:1988
-
负责人:Perumal Thiagarajan
-
依托单位:
PLATELET - FIBRINOGEN INTERACTIONS
-
批准号:3358135
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1988
-
负责人:Perumal Thiagarajan
-
依托单位:
PLATELET-FIBRINOGEN INTERACTIONS
-
批准号:3358132
-
项目类别:
-
资助金额:$13.17万
-
财政年份:1988
-
负责人:Perumal Thiagarajan
-
依托单位:
PLATELET-FIBRINOGEN INTERACTIONS
-
批准号:3358133
-
项目类别:
-
资助金额:$13.43万
-
财政年份:1988
-
负责人:Perumal Thiagarajan
-
依托单位:
PLATELET-FIBRINOGEN INTERACTIONS
-
批准号:2219749
-
项目类别:
-
资助金额:$17.84万
-
财政年份:1988
-
负责人:Perumal Thiagarajan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: